Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatmentXi Zhu, Yingjie Xu, Luisa M Solis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2017
Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung CancerWen Yu, Chad Tang, Brian P Hobbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2010
Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic featuresLuisa M Solis, Carmen Behrens, Wenli Dong, et al.
Clinical Lung Cancer|June 19, 2013
19q13-ERCC1 gene copy number increase in non--small-cell lung cancerElsa Vanhecke, Alexander Valent, Ximing Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancerMohamed Kabbout, Melinda M Garcia, Junya Fujimoto, et al.
Journal of Clinical Medicine|December 11, 2019
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC PatientsMaria Villalba, Francisco Exposito, Maria Jose Pajares, et al.
The Annals of Thoracic Surgery|August 30, 2011
Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resectionMin P Kim, Ying Chen, B Nebiyou Bekele, et al.
Oncotarget|December 17, 2016
The ISG15-specific protease USP18 regulates stability of PTENLisa Maria Mustachio, Masanori Kawakami, Yun Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapyErick Riquelme, Milind Suraokar, Carmen Behrens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2012
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapyApar Pataer, Neda Kalhor, Arlene M Correa, et al.
Pageof 17